* Products were supported by Award numbers R44EB013585, R42TR000377, R44TR000377, R43EY024848, R43EY025984, SB1EY027241, and R43EY028081 from the National Institutes of Health (NIH). The content is solely the responsibility of Eyenuk, Inc. and does not necessarily represent the official views of NIH.
** The devices are covered by one or more of the following US patents and their foreign counterparts: 8879813, 8885901, 9002085, and 9008391. Additional patents are pending.
EyeArt has US FDA clearance and Health Canada license for the autonomous detection of DR. It has CE marking as a class IIb medical device in the European Union, under EU MDR for the autonomous detection of DR, AMD, and glaucomatous optic nerve damage.
EyeMark™, EyeReadUWF™ have not yet been cleared for sales in any region.